<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 152 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page151.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=152">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 152 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 152</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=152"><img src="../thumb/152.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.9                                                 2020-04 / 121

                   THE NOAC* YOU AND YOUR PATIENTS CAN RELY ON


                     *NOAC = non-vitamin K oral anticoagulant

       myalg., arthralg., leg cramps, impot., flu-like sympts., UTI, URTI, sepsis   potens., chest pain, MI, hypotens., dyspn., cough, sinusit., prurit.,   fruct.intol., embryon.toxicit.& foet./neonat. morbid./mortal.dur.
       incl.fatal outcome, bld.dyscras., somnol., hypersens.reacts.incl.ana-  sweat., rash, eczema, erythema, urticar., weakn., myalg., musc. pain/  pregn., adeq. contracept.in women of childbear.potent., telmisartan
       phylax., hyperkalaem., hypoglycaem.in diab.pts., bradycard.,stomach   cramps, tendinit.-like sympts., asthen., flu-like illn., hepat.enzym.incr.,   excret.in milk of lactat.animals & amlodipine detect.in breastf.infts.
       discomf., eczema, drug erupt., tox. skin erupt., arthros., tendon pain,   hyperzotaem., oligur, ren.fail., dehydrat.  of treat.women, no data on safety & effic.in childr.bel.18  yrs., monit.
       ren. impairm., ac.ren.fail., asthen., decr.Hb, sialoadenit., inadeq.diab.  Warnings and special precautions: Treatm.to be stop.& chang.   digox./Li lev., monit. ren.funct./adeq.hydrat. when init.ther.& concom.
       control, electrol.imbal., vol. deplet., anorex., loss.of appetite, hyper-  if pregn.occurs/plan., monit. plasma digox.& Li lev.with concom.ther.,   NSAID, monit.with poss. dos. adjustm.dur.treatm.& aft.withdr.with
       cholesterolaem., hyperglycaem., restlessn., light-headedn., xanthops.,   adeq. hydrat.& monit.ren.funct.at begin.of combin. treatm.with con-  cert. anticonvuls./ rifampicin/Hypericum perforatum, concom. silde-
       ac.myop., ac.angle clos. glauc., vasculit., pancreatit., stomach upset,   com.NSAID’s, adeq.contracept.in women of childbear.potent., em-  nafil, dual block.of RAAS with ARB’s/ ACE inhibit./aliskiren assoc.
       cholestat.-/hepatocell. jaund., photosensit., skin reacts. incl.tox.epi-  broy.toxic./foet.& neonat.morbid.& mortal., incr.sepsis report., incr.   with high.freq. hypotens./ hyperkalaem.& decr.ren.funct., concom.
       derm.necrolysis, weakn., interstit. nephrit., ren.dysfunct., glycosur.,   sev.hypotens.& ren.insuffic.risk with bil.ren.artery stenos./ren.artery   grapefruit juice not recomm.
       fev., decr. urin.Ca excret., elev.ser.Ca, incr.urin.Mg excret.lead.to hy-  stenos.sngl.funct.kidn., pts.with mitral valve stenos., monit.ser.K &   Interactions: Incr.Li ser.conc.& toxic., incr. eff.with other anti-hyper-
       pomagnesaem., gluc.tol.impairm., latent diab.melit.manifestat., incr.   creatinine of risk pts., no exper.in ren.transplant., vol./Na deplet. to   tens., baclofen/ amifostine poss.potent.hypotens.eff., alcoh./ bar-
       cholester./ triglycerides, hyperuricaem., gout precipitat., poss. foet.   be correct.bef.init.ther., when vasc.tone & ren.funct.depend.predomin.  bits./ narcot./antidepress.aggrav.orthost. hypotens., reduc.eff.with
       electrol.disturbs.& other adult reacts., neonat. thrombocytopaen.,   on renin angiotensin-aldosterone syst.activ., concom.meds.affect.that   corticoster., incr.digox. plasma conc., incr.ramipril AUC & C max, poss.

       foet./neonat.jaund. with matern.thiaz.ther.  syst., not recomm.in prim.aldosteronism, concom.K spar.diuret./K    ac. ren. insuffic.in dehydat.pts./reduc.antihypertens. eff. with NSAID,
       Warnings and special precautions: Treatm.to be stop.& chang.if   supplem.or salt substit.contain.K/ meds poss.incr.ser.K lead to incr.  poss.incr.plasma conc.with ketoconazole/ itraconazole/ritonavir, K +
                                                                        +
       pregn.plann./confirm., dual block. of RAAS with ARB’s/ACE inhibit./  ser.K not recomm., mild to mod.hepat.impairm., baseline GI dis.as GI   spar.diuret. /K supplem./salt substit.contain.K /meds.that incr. K   +
                                                                                      +
                                                                          +
       aliskiren assoc. with high.freq.hypotens./hyperkalaem.& decr. ren.   bleed.report., less eff.in low.BP in black people, excess.BP reduct.in   lev.may incr.ser.K  lev, diltiazem.inhibit. amlodipine metabol., reduc.
       funct., concom.meds.that affect renin-angiotensin-aldosterone syst.,   ischaem.cardiopathy/ ischaem.card.vasc.dis.may result in MI/stroke.  amlodipine plasma conc. wirh CYP3A4 induc.e.g.cert.anticonvuls./
       mild to mod.ren. impairm., per.monit.of ser.electrol.& ren.funct. advis.,   Drug interactions: Incr.eff.of other anti-hypertens., incr.digox.plas-  rifampicin/ Hypericum perforatum, amlodipine & sildenafil each ex-
       no exper.in ren.transplant., correct vol./Na deplet. bef.init.ther., not   ma conc., incr.ser.Li conc. & toxic, ac.ren.insuffic.potent.with concom.   ert own BP low.eff.if used concom., dual block.of RAAS with ARB’s/
       recomm.in prim. aldosteronism/mitral stenos., monit.ser.K/ creatinine   NSAID’s in dehydrat.pts., reduc.antihypertens. eff. with NSAID’s.  ACE inhibit./ aliskiren assoc.with high.freq.hypotens./ hyperkalaem.&
       & uric acid of risk pts., contain.K/meds. that incr.K lev., hypokalaem.  decr.ren.funct., ac.kidn.injury with concom. fluoroquinolones, incr.BP
       risk great.in liv. cirrhos./brisk diuresis/ inadeq.oral electrol.intake &   TWYNSTA, Ing.Pharm. [P/S] &  low.effs.with grapefruit juice.
       concom.corticoster. ACTH, discont. ther.bef.test. parathyroid funct.in   Telmisartan 40(40; 80; 80) mg, amlodipine 5(10; 5; 10) mg  See also MDR page 281.
       case of mark.hypercalcaem., monit. for warn.signs of fluid & electrol.  Indications: Replacem.ther.in essent.hypertens. in pts. stabilis. on
       imbal., mild to mod.hepat.impairm./progress.liv.dis., poss. adjustm.to   same dos.of indiv.compon., add-on ther.in pts.not adeq.control.on   VALDUO, Forrester [P/S]
       insul./oral antidiabet.dos., in diabet. with addit.CV risk fatal MI& un-  amlodipine monother.  Amlodipine 5 mg, valsartan 160 mg.
       expect.CV death incr. with with BP low.med., diagnost.eval.for coron.   (S3) TABS, 44/7.1.3/0857, 0858, 0859, 0860  Amlodipine 10 mg, valsartan 160 mg.
       artery dis in pts.with diab.mellit.bef. init.ther., SLE exacerbat./activat.,   717366-001: 40/5 mg, 28, R277,64  Indications: Mild to mod.essent.hypertens.in pts. stabilis.on same
       excess.BP reduct. in ischaem.cardiopathy/ischaem.CV dis. may result   717367-001: 40/10 mg, 28, R316,05  dos.of indiv.compon.
       in MI/stroke, hypersens.more likely in allergy/ bronch.asthma hist.,   717368-001: 80/5 mg, 28, R277,64  (S3) TABS. 51/7.1.3/0068, 0069
       hydrochlorothiaz.to be discont. if ac.myop.& second.angle-clos.glauc.   717369-001: 80/10 mg, 28, R316,05  3000682-001, 5/160 mg, 30, R190,00
       develop, hist.of penicill.& sulphonamide allergy poss. risk fact.for   Dosage: Admin.once dly.  3000683-001, 10/160 mg, 30, R220,00
       develop.ac.angle-clos.glauc., lact. intol., concurr.hypovolaem.poss.  Replacem.ther: Admin.1 tab./day contain.the same compon. of the   Dosage: Pts.using same compon.dos.from separ. tabs.may be switch.
       induc. ren. fail., monit.ser.Ca lev./adjust Ca dos.if Ca supplem. reqd.,   telmisartan & amlodopine dos.when tak.separately.  Recomm.dos: 1 tab./day.
       adeq.contracept.in women of childbear. age, fetotox.risk dur.expos.  Add-on ther: May be admin.if BP not adeq.contr. with amlodi-  Contraindications: Angio-oed.with prev.ACE-inhibit./ angiotens.
       in pregn., ultrasound of foet.ren.funct./skull recomm.in case of ex-  pine alone. Start.dos: Usual.40/5 mg once dly. Dos.may be titrat.  recept.block., heredit./idiopath. angioed., hypertroph.obstruct.car-
       pos.dur.pregn., infts.whose mothers receiv. ther. to be observ.for hy-  up to a max.of 80/10 mg once dly if addit.BP lower.need.aft.at   diomopathy, aort. stenos., sev.ren.impairm., bilat.& unilat.ren.artery
                                                                          +
       potens., thiaz.cross. placenta barrier & appear in human milk/cord   least 2 wks of ther.  stenos., concom.K spar.diurets., porphyr., Li.ther., safety in pregn.&
       bld. & may inhib.lactat., no data on safety & effic.in childr.up to 18   Contraindications: Dihydropyrid.derivat. hypersens., angioed.hist.  lactat.not est., safety & effic.in childr. & adolesc.und.18 yrs.not est.,
                    -
                          -
       yrs., monit.digox.lev., concom.Kspar.diuret./Ksupplem./salt substit.,   link.to prev.ACE inhibit./ angiotensin recept.block., heredit./idiopath.   sev. hypotens., shock, haemodynamic.unstable heart fail. aft.ac.MI,
                                 +
       adeq.hydrat. & reg.ren.funct.monit.init.& dur., freq.monit. ser.K  with   angioed., hypertroph.obstruct.cardiomyopathy, sev.ren./liv.funct.im-  concom. renin inhibits.incl. aliskiren-contain.meds.
                   +
       concom.meds.affect.by ser.K  disturbs., treatm.with concom. NSAID’s.  pairm., bil.ren.artery stenos., ren.artery stenos.with sngl.kidn., aort.  Side effects: Amlodipine/valsartan: Freq: Hypokalaem.,
                                             +
       Interactions: Incr.Li ser.conc.& toxic., incr.eff.of other anti-hypertens.,   stenos., concom. K spar.diuret., porphyr., Li-ther., pregn.& lactat.,   headache, hot flush., nasopharyngit., influenza, fatig., asthen., oed.
       antihypertens./natriuret.& diuret. eff. weak.by NSAID’s, incr.digox.  concom.aliskiren-contain.products, bil. obstruct. disords., cardiogen.  Less freq: Hypersens., anorex., hypercalcaem., hyperglycaem.,
       plasma conc., incr.ramipril AUC & C max, reduc.ren.excret.of cytotox.   shock, concom. fluoroquinolones in mod.-sev.ren.impairm.& elderly.  hyperlipidaem., hyperuricaem., hyponatraem., anx., dizzin.,
       drugs & potent. myelosuppress.effs., haemolyt. anaem.with methyl-  Side effects: Common: Dizzin., periph oed. Uncommon: Somnol.,   somnol., postur. dizzin., paraesthes, vis.disturbs., vertigo, tinnit.,
       dopa, incr.advers. effs. from amantadine, alcoh./barbits./narcots.   migraine, headache, paraesthes., vertigo, bradycard., palpitat., hypo-  tachycard., palpitat., orthostat.hypotens, hypotens., syncope, cough,
       poss. potent.orthostat.hypotens., cholestryamine/ colestipol imp.  tens., orthostat.hypotens., flush., cough, abdom.pain, diarrh., naus.,   pharyngolaryng.pain, diarrh., naus., vomit., abdom.pain, constip.,
       HCTZ absorpt., lact.acidos.risk with metformin, pressor.amines eff.  prurit., arthralg., myalg., musc. spasm, back pain, erect.dysfunct., as-  dry mouth, rash, erythema., exanthema, prurit., hyperhidros., joint
       decr., hypokalaem. & hypomagnesaem. may favour onset of digox.-  then., chest pain, fatig., oed., incr.hepat.enzym., UTI, URTI, anaem.,   swell., back pain, arthralg., musc. spasm, sensat.of heavin., pollakiur.,
       induc. card.dysrhythm., eff.of non-depolar.skelet. musc. relaxant. po-  hyperkalaem., dyspn., flatul., hyperhidros., imp.ren.funct., incr.bld.  polyur., erect. dysfunct. Amlodipine: Freq: Headache, somnol.,
       tent., poss.uricosur.med.dos. adjustm.as ser.uric acid lev.rais., incr.in-  creatinine. Rare: Cystit., depress., anx., insomn., syncope, periph.  dizzin., migraine., palpitat., tachycard., flushing, naus., vomit.,
       cid.of hypersens. reacts. to allopurinol, vit.D or Ca salts potent.rise in   neuropathy, hypoaesthes., dysgeus., trem., vomit., gingiv.hypertrophy,   abdom.pain. Less freq: Leucopen., thrombocytopen., angioed.,
       ser.Ca, enhanc.hyperglycaem.eff.of beta-block.& diazoxide, anticho-  dyspeps., dry mouth, eczema, erythema, rash, extremity pain, noctur.,   erythema multiforme, hyperglycaem., depress., mood chang., periph.
       linerg.agents incr.bioavail., cyclospor. may incr.risk of hyperuricaem.   malaise, incr.bld.uric acid, sepsis somet.fatal, eosinophil., thrombo-  neuropathy, trem., vis.disturbs., eye pain, vertigo, angina, bradycard.,
       & gout type complicat., kaliuret. diuret./ laxativ./corticoster./ ACTH/  cytopen., angioed., anaphylact. reacts., hypersens., hypoglycaem.,   vasculit., syncope, hypotens., orthostat. hypotens., dyspn., rhinit.,
       amphotericin/ carbenoxolone/ penicill.G & salicylic.acid & deriv. may   vis.disturbs., tachycard., stomach discomf., abnorm. hepat.funct./  altered bowel habits, dyspeps., gastrit., gingiv. hyperplas., dry
                -
                      -
       incr.hypokalaem.eff., Kspar.diuret./Ksupplem./ salt substit.contain.K/  liv.disord.,urticar., drug/tox. skin erupt., tendon pain, flu-like illn., Hb   mouth, constip., pancreatit., hepatit., jaund., alopec., prurit., rash,
       meds.that incr.K lev. may incr.ser.K lev.  decr., CPK incr. Freq.unknown: Leucopen., hyperglycaem., mood   myalg., arthralg., back pain, musc.cramps, incr.urin.freq., micturit.,
                                     chang., confus.state, extra pyramid.disord., vis.impairm., tinnit., MI,
                                                                  gynaecomast., impot., incr.sweat., malaise, asthen. Valsartan Freq:
       TESAR, Pharma Dynamics [P/S]  dysrhythm., ventr. tachycard., atrial fibrillat., vasculit., rhinit., bowel   Vir.infect., postur. dizzin., orthostat.hypotens., neutropen. Less freq:
       Telmisartan                   habit changes, pancreatit., gastrit., jaund., hepatit., hepat.enzyme   Thrombocytopen., hypersens.incl.ser. sickn., angioed., hyperkalaem.,
       Indications: Mild to mod.hypertens.alone/ combin. with hydro-  elev., alopec., purpura, skin discolourat., erythema multiforme, exfo-  insomn., dizzin., headache., blurr.vis., vertigo, card.fail., hypotens.,
       chlorothiazide.               liat. dermatit., Stev.-John.syndr. photosens., micturit. disords., pol-  vasculit., syncope., URTI, pharyngit., sinusit., rhinit., cough., diarrh.,
       (S3) TABS, 45/7.1.3/0978, 0979  lakiur., gynaecomast., weight chang.  abdom.pain, naus., rash, prurit., alopec., urticar., back pain, arthralg.,
       721678-001: 40 mg, 30, R129,83  Warnings and special precautions: Discont.& chang.to diff.  myalg., rhabdomyolys., ren.impairm./ insuffic., ac.ren.fail, decr.libido.,
       721679-001: 80 mg, 30, R142,55  meds.class if pregn.occurs/if pregn. plann., bil.obstruct.disords.,   fatig., asthen., oed. Freq unknown: Hepatit.
       Dosage: Recomm.dos: 40 mg once dly. Max: 80 mg once dly.   hepat.insuffic., mild to mod.liv.funct.impairm., incr.sev.hypotens.  Warnings and special precautions: No re-challenge aft.angioed.
       Addit.BP lower.eff.can be achiev .in combinat.with low dos. hy-  risk/ ren. insuff.in bil.art.stenos./art.stenos.to sngl.kidn., no exper.in   react., high.freq.of hypotens./ hyperkalaem.& decr.ren.funct.with
                                               +
       drochlorothiaz. (12,5 mg). Max.anti-hypertens. eff.is gen.attain.4-8   kidn.transpl., monit.ser.K -/creatin.lev.in pts.at risk, correct.vol./salt   dual block.of RAAS, symptomat.hypotens., concom. Li ther., discont.
       wks. aft.start of treatm.     deplet.bef.init.ther., when vasc.tone & ren.funct.depend.predomin.on   if pregn.confirm./plann., effect. contracept.in women of childbear.
       Mild to mod.hepat.impair: Do not exceed 40 mg once dly.  renin-angiotensin-aldosterone syst.activ., assess.ren.funct.bef.init.   potent., hepat./ sev.ren.impairm., bil.obstruct.disords., concom. K - +
                                                                        +
                                                                                          +
       Contraindications: Hyperkalaem, angioed. hist. link.to prev.ACE   treatm. & monit. dur.treatm.with fluoroquinolones/ACE inhibit./ an-  spar.diuret./K  supplem./K salt substit. or meds.incr. K lev., Na &
                                                                              +
       inhibit./angiotensin recept.block., heredit./idiopath.angioed., hy-  giotens. recept.blocker whether used separat/ concom., not recomm.  vol.deplet. theref. correct.bef.init. her., avoid concom. dantrolene.
                                                                                         +
       pertroph.obstruct. cardiomyopathy, sev.ren.impairm., bil. ren. artery   in prim.aldosteronism, no data with unstab.ang.pect./within 1 mnth.  Interactions: Ser.Li conc.incr./toxic., incr.K  lev with K -spar.diuret./
                                                                                    +
       stenos., ren.artery stenos.sngl.funct.kidn., aort. stenos., concom.Li/K +   of MI, HF of non-ischaem.aetiology., monit.ser.K  in pts.at risk.esp.  K  supplem.or K salt substit./ other meds.that may incr.K  lev.incl.
                                                                   +
                                                                                           +
                                                                         +
                                                         +
       spar.diuret., porphyr., pregn., lactat., fruct.intol., sev.hepat.impairm.,   in pres.of ren.impairm.&/or HF, concom. K spar.diuret./K supplem./  heparin., hyperkalaem. with dantrolene, incr.amlodipine bioavail.
                                                      +
                                                            +
       bil. obstruct. disords., safety & effic.in childr.und.18 yrs. not est.  salt substit. contain. K / meds.that incr.K  lev., incr.MI & unexpect.   with grapefruit/-juice incr.BP low eff., strong-mod. CYP3A4 inhibit.
                                              +
                                                      +
       Side effects: UTI, URTI, eosinophil., thrombocytopen., neutropen.,   CV death in diabet.pts.if coexist. coron.arter.dis asymptomat./undi-  may signific. incr. amlodipine expos., poss.low.amlodipine plasma
       hypersens.reacts., angio-oed., depress., insomn., anx., headache,   agn.theref. appropr. diagnos.eval.necess., excess.BP reduct.in pts.   conc.with CYP3A4 induc., expos.of concom. simvastatin incr., anti-
       dizzin., fatig., vis.disturbs., vertigo, CHF, bradycard., tachycard., hy-  with ischaem.cardiopathy/ischaem.CV dis.may result in MI/ stroke,   hypertens.eff.attenuat.by NSAID’s, incr.K / risk of ren.funct.worsen.
                                                                                   +
                            S4 Pradaxa ® . 110 mg. Each capsule contains 110 mg of dabigatran etexilate base (as mesilate salt). Reg. No. 42/8.2/0131. S4 Pradaxa ® . 150 mg. Each capsule contains 150 mg of dabigatran
                            etexilate base (as mesilate salt). Reg. No. 45/8.2/0162. For full prescribing information refer to the professional information approved by the Regulatory Authority.
                            Applicant details: Ingelheim Pharmaceuticals (Pty) Ltd, 407 Pine Ave, Randburg. Tel: +27 (011) 348-2400. Cpy. Reg. No. 1966/008618/07. BI Ref. No. PC-ZA-100406. Expiry date: August 2021.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page151.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>
             </td>
             <td width="35%"><a href="page153.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page153.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
